Works matching DE "MYELOMA proteins"


Results: 725
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Yellow Changes of the Skin: A Quiz.

    Published in:
    Acta Dermato-Venereologica, 2015, v. 95, n. 6, p. 762, doi. 10.2340/00015555-2066
    By:
    • Verdolini, Roberto;
    • Arkoumani, Evdokia;
    • Pandya, Darshna;
    • Parmar, Sanjay;
    • Altamura, Davide
    Publication type:
    Article
    16
    17
    18

    Real-world effectiveness and safety of daratumumab, bortezomib, and dexamethasone in relapsed/refractory multiple myeloma in Slovakia.

    Published in:
    Neoplasma, 2021, v. 68, n. 3, p. 626, doi. 10.4149/neo_2021_201113N1223
    By:
    • HARVANOVÁ, Ľubica;
    • ŠTULAJTEROVÁ, Viera;
    • GUMAN, Tomáš;
    • LADICKÁ, Miriam;
    • HLEBAŠKOVÁ, Monika;
    • CHUDEJ, Juraj;
    • ŠIMEK, Miroslav;
    • ŠTECOVÁ, Natália;
    • FLOCHOVÁ, Emília;
    • KUBALA, Ján;
    • SIMANČÍKOVÁ, Iveta;
    • DRGOŇA, Ľuboš;
    • VRANOVSKÝ, Andrej;
    • WILD, Alexander;
    • MISTRÍK, Martin;
    • BÁTOROVÁ, Angelika
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    In this issue.

    Published in:
    Journal of Clinical Investigation, 2004, v. 113, n. 12, p. 1661
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39

    Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma.

    Published in:
    Cancer Immunology, Immunotherapy, 2016, v. 65, n. 8, p. 983, doi. 10.1007/s00262-016-1861-2
    By:
    • Lee, Sung-Eun;
    • Lim, Ji-Young;
    • Ryu, Da-Bin;
    • Kim, Tae;
    • Yoon, Jae-Ho;
    • Cho, Byung-Sik;
    • Eom, Ki-Seong;
    • Kim, Yoo-Jin;
    • Kim, Hee-Je;
    • Lee, Seok;
    • Cho, Seok-Goo;
    • Kim, Dong-Wook;
    • Lee, Jong-Wook;
    • Min, Woo-Sung;
    • Kim, Myungshin;
    • Min, Chang-Ki
    Publication type:
    Article
    40
    41

    Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC.

    Published in:
    Cancer Immunology, Immunotherapy, 2013, v. 62, n. 12, p. 1841, doi. 10.1007/s00262-013-1493-8
    By:
    • Collins, Shauna M.;
    • Bakan, Courtney E.;
    • Swartzel, Gina D.;
    • Hofmeister, Craig C.;
    • Efebera, Yvonne A.;
    • Kwon, Hakju;
    • Starling, Gary C.;
    • Ciarlariello, David;
    • Bhaskar, Shakthi;
    • Briercheck, Edward L.;
    • Hughes, Tiffany;
    • Yu, Jianhua;
    • Rice, Audie;
    • Benson Jr., Don M.
    Publication type:
    Article
    42
    43
    44
    45

    Immunochemical Diagnosis of Multiple Myeloma.

    Published in:
    Bulletin of Experimental Biology & Medicine, 2018, v. 165, n. 1, p. 84, doi. 10.1007/s10517-018-4105-y
    By:
    • Lyubimova, N. V.;
    • Timofeev, Yu. S.;
    • Abaev, V. M.;
    • Votyakova, O. M.;
    • Kushlinskii, N. E.
    Publication type:
    Article
    46
    47
    48
    49
    50